Current filters:


73 to 82 of 98149 results

Farmaindustria defends the non-interchangeability principle for biologic and biosimilar medicines


Speaking at the first Biological Medicines Forum organized by the Associations last week, the president…

BiosimilarsBiotechnologyPatents & Trade marksRegulationSpain

Bayer to continue expansion in Russian pharma market


German pharma major Bayer plans to continue expansion in the Russian pharmaceutical market this year,…

AveloxBayerMarkets & MarketingPharmaceuticalProductionRussia

Aurobindo gains tentative US FDA approval for generic Vimpat


Indian drugmaker Aurobindo Pharma has received tentative approval from the US Food and Drug Administration…

Aurobindo PharmaGenericslacosamide Tablet and InjectionLegalNeurologicalRegulationUCBUSAVimpat

Biogen Idec shares up on positive early-stage results for Alzheimer’s candidate aducanumab


US biotech major Biogen Idec has announced data from a pre-specified interim analysis of PRIME, the Phase…

aducanumabBIIB037Biogen IdecBiotechnologyNeurologicalResearch

Lilly and Innovent collaborate to bring potential cancer drugs to market


US pharma major Eli Lilly has joined forces with Innovent Biologics, a leading Chinese biotech firm,…

ChinaEli LillyGlobalInnovent BiologicsLicensingOncologyPharmaceuticalResearch

Amgen files for Repatha approval in Japan


Leading USA-based biotech firm Amgen has filed for approval of Repatha (evolocumab) for the treatment…

AmgenAstellas PharmaBiotechnologyCardio-vascularevolocumabJapanRegulationRepatha

73 to 82 of 98149 results

Back to top